Large-scale testing (Phase 3)Looking for participantsNCT07413939
What this trial is testing
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Who this might be right for
HER2-positive Breast Cancer
Hoffmann-La Roche 650